Mice of groups B and C, which received either [177Lu]Lu-DOTA-folate or the anti-CTLA-4 antibody, respectively (Fig. 4b,c), showed only ~ 10–40% delayed tumor growth compared with the controls (Fig. 4e, Supplementary Material Table S3). Here, CTLA4 is linked to neoplasm.